Halozyme Therapeutics to acquire Antares Pharma in all-cash deal
The transaction, which values Antares at $960 million, demonstrates Halozyme's commitment to drug delivery.
The transaction, which values Antares at $960 million, demonstrates Halozyme's commitment to drug delivery.